Catalyst

Slingshot members are tracking this event:

PDUFA date for Ocrevus (Ocrelizumab) BLA in RMS and PPMS Pushed Back to March 28, 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BIIB

100%

Additional Information

Additional Relevant Details Update on December 20th: Original PDUFA date was December 28, 2016
http://www.gene.com/...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 29, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ocrevus, Ocrelizumab, Bla Filing, Relapsing Forms Multiple Sclerosis, Ppms